Loading company…
Tensegrity Pharma provides drug discovery services and develops treatments for unmet medical needs.
Tensegrity Pharma provides drug discovery services to pharmaceutical companies, focusing on advancing candidates toward clinical validation. Founded in 2023 by CEO Takahito Nakahara, Ph.D., the company is based in Tokyo, Japan. In November 2024, it raised JPY 500 million in seed funding from Newton Biocapital Partners. The funding will support development of a treatment for cachexia, or wasting syndrome.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in